Pharmacokinetic and metabolic aspects of parsalmide in various animal species and man
Fleischmann, L.
Bollettino Chimico Farmaceutico 119(7): 385-390
1980
ISSN/ISBN: 0006-6648 PMID: 6893933 Document Number: 167048
Document emailed within 1 workday
Related Documents
Fleischmann, L.; Lavezzo, A.; Colombo, L. 1976: Parsalmide: a new anti-inflammatory agent. V. Pharmacokinetic and metabolic aspects in the rabbit Bollettino Chimico Farmaceutico 115(2): 175-182Phillipson, C.E.; Ioannides, C. 1989: Metabolic activation of polycyclic aromatic hydrocarbons to mutagens in the Ames test by various animal species including man Mutation Research 211(1): 147-151
Fehri, B.; Aiache, J.M.; Boukef, K. 1988: Extrapolation of pharmacokinetic results from one species to another Journal de Pharmacie de Belgique 43(5): 382-389
Wegner, W. 1991: Animal welfare aspects of animal breeding Deutsche Tierärztliche Wochenschrift 98(1): 6-9
Picard-Fraire, C. 1984: Pharmacokinetic and metabolic characteristics of ticlopidine in relation to its inhibitory properties on platelet function Agents and Actions. Supplements 15: 68-75
Gerlitz, S.; Wessel, G.; Wieberneit, D.; Wegner, W. 1993: The problems of breeding spotted rabbits. 3. Variability of the pigmentation grade, ganglionic intestinal wall supply, relationship to pathogenesis--animal breeding and animal welfare aspects Deutsche Tierärztliche Wochenschrift 100(6): 237-239
Ritschel, W.A. 1982: Pharmacokinetic aspects of analgesics Methods and Findings in Experimental and Clinical Pharmacology 4(7): 479-487
Mota, I. 1986: IgG subclasses in animal species Monographs in Allergy 19: 302-312
Dyderski, S. 1999: Pharmacokinetic aspects of geriatric therapy Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 7(37): 29-32
Orwig, B.A.; Dugger, H.A.; Bhuta, S.I.; Talbot, K.C.; Schwarz, H.J. 1981: The biotransformation of fluproquazone in man and several animal species Arzneimittel-Forschung 31(5a): 904-911
Motta, G.; Malberti, R. 1975: Amoxicillin: microbiological, pharmacokinetic and therapeutic aspects Il Farmaco; Edizione Pratica 30(8): 357-373
Covino, B.G. 1984: Pharmacodynamic and pharmacokinetic aspects of local anesthetics Annales Chirurgiae et Gynaecologiae 73(3): 118-122
Rubiolo, E.R. 1981: Immunogenicity of Trypanosoma cruzi in different animal species Acta Physiologica Latino Americana 31(3): 199-206
Vincent, D.; Perrier, H.; Rouzioux, J.M. 1970: Isoenzymes of serum cholinesterase in several animal species Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 164(8): 1767-1769
Dengler, H.G.; Hengstmann, J.H. 1976: Metabolism and pharmacokinetics of orciprenaline in various animal species and man Archives Internationales de Pharmacodynamie et de Therapie 223(1): 71-87
Fugate, H.G.; Penn, S.R. 1971: Immunodiffusion technique for the identification of animal species Journal - Association of Official Analytical Chemists 54(5): 1152-1156
Carbon, C.; Crémieux, A.C.; Fantin, B. 1993: Pharmacokinetic and pharmacodynamic aspects of therapy of experimental endocarditis Infectious Disease Clinics of North America 7(1): 37-51
Pfeifer, G.; Frenkel, C.; Entzian, W. 1985: Pharmacokinetic aspects of cerebrospinal fluid penetration of fosfomycin International Journal of Clinical Pharmacology Research 5(3): 171-174
Ritschel, W.A.; Brady, M.E. 1979: Animal model for pharmacokinetic approach to individualized heparin dosage regimen for I.v. infusion by constant rate to achieve and maintain a desired clotting time Arzneimittel-Forschung 29(12): 1891-1894
Gulyĭ, M.F.; Golubeva, L.I.; Boĭko, V.B. 1983: Various metabolic reactions of glycine in the animal organism Ukrainskii Biokhimicheskii Zhurnal 55(4): 372-375